R
Rolf Terlinden
Researcher at Grünenthal GmbH
Publications - 14
Citations - 757
Rolf Terlinden is an academic researcher from Grünenthal GmbH. The author has contributed to research in topics: Tapentadol & Cmax. The author has an hindex of 11, co-authored 14 publications receiving 702 citations.
Papers
More filters
Journal ArticleDOI
Mechanistic and functional differentiation of tapentadol and tramadol
Robert B. Raffa,Helmut Buschmann,Thomas Christoph,Gary Eichenbaum,Werner Englberger,Christopher M. Flores,Torsten Hertrampf,Babette Kögel,Klaus Schiene,Wolfgang Strasburger,Rolf Terlinden,Thomas M. Tzschentke +11 more
TL;DR: Tapentadol, a schedule-II controlled substance, is well-suited for pain conditions requiring a strong opioid component—and it has the benefit of greater gastrointestinal tolerability compared to classical strong opioids.
Journal ArticleDOI
Synergistic Interaction between the Two Mechanisms of Action of Tapentadol in Analgesia
Wolfgang P. Schröder,Thomas M. Tzschentke,Rolf Terlinden,J. De Vry,U. Jahnel,Thomas Christoph,Ronald J. Tallarida +6 more
TL;DR: A very pronounced synergistic interaction between the two mechanisms of action of tapentadol is demonstrated, probably the first demonstration of a synergistic interactions between the occupied receptors for a single compound with two mechanism of action.
Journal ArticleDOI
Absorption, metabolism, and excretion of 14C-labeled tapentadol HCl in healthy male subjects.
TL;DR: It was found that a single oral dose of tapentadol was rapidly absorbed, then excreted into the urine, primarily in the form of conjugated metabolites, and was well tolerated.
Journal ArticleDOI
Investigations Into the Drug-Drug Interaction Potential of Tapentadol in Human Liver Microsomes and Fresh Human Hepatocytes
TL;DR: The new analgesic tapentadol was evaluated for induction and inhibition of several cytochrome P450 enzymes in vitro, and protein binding was assessed.
Journal ArticleDOI
In vitro and in vivo characterization of tapentadol metabolites.
TL;DR: It is highly unlikely that tapentadol forms metabolites that contribute in any relevant degree to its analgesic activity, as most of these metabolites had no analgesic effects in the tail-flick test in mice.